Search

everythinglearnresearchcommunity

for

Search:↓

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

Some patients' hair grew back black and white after chemotherapy.

Tofacitinib might be used to treat hair loss.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Eruca sativa oil, Aloe vera oil, and sodium carbonate may help improve cholesterol and tumor markers in breast cancer treatment.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

XEDAR triggers a specific signaling pathway in cells.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Cancer treatments often cause skin, nail, and hair problems.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Imatinib can cause hair loss due to lichen planopilaris.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Eclipta alba phytosomes improve bioavailability and therapeutic effects.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

EGFR inhibitors can cause yellowish skin eruptions.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

CTP-543 is generally safe for treating alopecia areata.

Wedelolactone may help treat chronic diseases due to its strong antioxidant properties.